Psychotropic Medication Management in Autism Spectrum Disorders
Summary
Management of behavioural and emotional symptoms in autism spectrum disorders (ASD) often includes psychotropic medications to address comorbid conditions such as attention-deficit/hyperactivity disorder, anxiety, mood disturbances and irritability. Current practice balances the limited number of agents approved for core ASD-associated behaviours—principally atypical antipsychotics for irritability—with off-label use of stimulants, antidepressants, mood stabilisers and hypnotics to target co-occurring symptoms. Prescribing patterns vary widely by region, healthcare setting and patient characteristics, reflecting differences in clinical guidelines, regulatory approvals and access to specialist services. Polypharmacy is common, driven by complex symptom profiles and overlapping psychiatric diagnoses, but raises concerns about long-term safety, metabolic effects and pharmacodynamic interactions. Personalised approaches that integrate behavioural interventions, close monitoring of efficacy and adverse events, and shared decision-making with families are increasingly advocated. Emerging research explores digital screening tools, registry-based monitoring and pragmatic trial designs to optimise treatment selection, dosing strategies and follow-up protocols, with the ultimate aim of improving functional outcomes and quality of life for individuals with ASD worldwide.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Psychotropic Medication Management in Autism Spectrum Disorders publication trend
The graph below shows the total number of articles in psychotropic medication management in autism spectrum disorders across all publications each year (not limited to Nature Index journals).
Technical terms
Autism Spectrum Disorder: A neurodevelopmental condition characterised by social communication differences and restricted, repetitive behaviours.
Comorbidity: The co-occurrence of one or more additional psychiatric or medical conditions alongside ASD.
Polypharmacy: The concurrent use of two or more medications from the same or different psychotropic classes.
Antipsychotics: Medications primarily used to treat irritability, aggression or psychotic symptoms, often prescribed off-label in ASD.
Stimulants: Drugs that enhance attention and reduce hyperactivity, frequently used to manage ADHD symptoms in ASD.
References
- Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid. Journal of Autism and Developmental Disorders (2023).
- Psychotropic Medications Use among Children with Autism in Saudi Arabia. Children (2022).
- A Retrospective Chart Review of Factors Impacting Psychotropic Prescribing Patterns and Polypharmacy Rates in Youth with Autism Spectrum Disorder during the COVID-19 Pandemic. Journal of Clinical Medicine (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.